Charlene A. Banard is EVP & Chief Technical Officer at Atara Biotherapeutics, Inc. (ATRA). They have made 1 open-market trade across 1 company since 2023, most recently 2023-05-16.
CIK 0001919506
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ATRA | 276,010 | $2.6M |
Shares reported on the most recent Form 4, priced at the 2023-05-18 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ATRA | SELL | 2023-05-16 | 2023-05-18 | $2.04 | $39K | -26.4% | -8.2% | -18.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.